US Stock MarketDetailed Quotes
FULC Fulcrum Therapeutics
- 3.025
- +0.035+1.17%
Trading Nov 21 14:42 ET
163.16MMarket Cap-10431P/E (TTM)
3.080High2.955Low297.59KVolume3.020Open2.990Pre Close903.14KTurnover0.91%Turnover RatioLossP/E (Static)53.94MShares13.70052wk High0.63P/B99.23MFloat Cap2.86052wk Low--Dividend TTM32.80MShs Float33.098Historical High--Div YieldTTM4.18%Amplitude2.250Historical Low3.034Avg Price1Lot Size
Fulcrum Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 16.74%-19.07M | 383.37%58.9M | -4.84%-25.28M | 6.27%-90.97M | -17.58%-23.16M | 17.85%-22.91M | 24.05%-20.79M | -9.09%-24.12M | -23.67%-97.05M | 9.89%-19.7M |
| Net income from continuing operations | 9.66%-21.7M | 332.98%55.41M | -8.44%-26.87M | 11.41%-97.34M | 5.28%-24.76M | -1.18%-24.02M | 30.19%-23.78M | 4.43%-24.78M | -35.90%-109.87M | -11.29%-26.14M |
| Depreciation and amortization | -30.51%369K | -33.69%376K | -15.37%479K | -10.02%2.17M | -14.04%508K | -13.09%531K | -16.12%567K | 5.60%566K | -4.02%2.41M | -4.83%591K |
| Change In working capital | 73.92%-410K | -112.31%-96K | 40.93%-1.65M | -49.10%-4.61M | -132.43%-1.03M | 80.88%-1.57M | -72.74%780K | -205.25%-2.79M | 73.98%-3.09M | 200.16%3.18M |
| -Change in receivables | -1,840.79%-1.32M | -318.85%-2.33M | 313.08%537K | -109.04%-308K | -92.51%43K | -74.41%76K | -86.91%-557K | -95.41%130K | 408.14%3.41M | 123.25%574K |
| -Change in prepaid assets | -250.29%-2.42M | -39.40%463K | 253.83%803K | -530.59%-1.07M | -181.20%-622K | 27.99%-692K | 1,176.06%764K | -643.75%-522K | -26.87%-170K | 75.69%766K |
| -Change in payables and accrued expense | 369.48%1.6M | 107.17%1.94M | -33.63%-2.82M | -170.21%-1.68M | -96.27%92K | 91.53%-593K | -83.92%934K | -11.81%-2.11M | -121.25%-621K | 546.98%2.47M |
| -Change in other current assets | 38,160.00%1.91M | -102.78%-1K | -68.92%23K | 106.02%94K | -250.00%-21K | -28.57%5K | 102.79%36K | 127.01%74K | -4,438.89%-1.56M | 73.91%-6K |
| -Change in other working capital | 52.72%-174K | 59.70%-160K | 47.37%-190K | 60.26%-1.65M | 15.65%-523K | 34.05%-368K | 69.18%-397K | 78.55%-361K | 69.51%-4.15M | 58.64%-620K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 16.74%-19.07M | 383.37%58.9M | -4.84%-25.28M | 6.27%-90.97M | -17.58%-23.16M | 17.85%-22.91M | 24.05%-20.79M | -9.09%-24.12M | -23.67%-97.05M | 9.89%-19.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -77.13%4.35M | -162.93%-12.51M | 140.59%38.13M | -395.59%-36.69M | 150.48%18.35M | 934.58%19.02M | -36.69%19.88M | -577.85%-93.94M | 109.57%12.41M | -299.85%-36.36M |
| Net PPE purchase and sale | 70.77%-19K | --0 | 83.63%-28K | 74.12%-508K | 33.62%-77K | 77.03%-65K | 85.20%-195K | 30.49%-171K | -14.59%-1.96M | 77.65%-116K |
| Net investment purchase and sale | -77.11%4.37M | -162.32%-12.51M | 140.69%38.16M | -351.70%-36.18M | 150.85%18.43M | 1,056.16%19.09M | -38.65%20.07M | -571.09%-93.77M | 111.24%14.38M | -322.69%-36.25M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -77.13%4.35M | -162.93%-12.51M | 140.59%38.13M | -395.59%-36.69M | 150.48%18.35M | 934.58%19.02M | -36.69%19.88M | -577.85%-93.94M | 109.57%12.41M | -299.85%-36.36M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 635K | 165.49%377K | -98.60%1.65M | 40.08%118.12M | 31.65%287K | 0 | -94.95%142K | 33,719.83%117.69M | -54.79%84.32M | -75.53%218K |
| Net common stock issuance | --0 | --0 | --0 | 45.22%117.35M | --0 | --0 | --0 | --117.35M | -55.81%80.8M | 36.36%-49K |
| Proceeds from stock option exercised by employees | --635K | 165.49%377K | 374.43%1.65M | -77.92%777K | 7.49%287K | --0 | -94.95%142K | 0.00%348K | -4.06%3.52M | -72.45%267K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --635K | 165.49%377K | -98.60%1.65M | 40.08%118.12M | 31.65%287K | --0 | -94.95%142K | 33,719.83%117.69M | -54.79%84.32M | -75.53%218K |
| Net cash flow | ||||||||||
| Beginning cash position | 150.78%87.92M | 14.86%41.15M | -26.35%26.66M | -0.86%36.19M | -66.13%31.17M | -15.00%35.06M | 4.13%35.83M | -0.86%36.19M | -37.22%36.5M | 38.26%92.03M |
| Current changes in cash | -262.51%-14.09M | 6,189.58%46.77M | 4,082.14%14.5M | -2,936.62%-9.54M | 91.91%-4.52M | -107.65%-3.89M | -111.23%-768K | 82.66%-364K | 98.55%-314K | -85.76%-55.84M |
| End cash Position | 136.85%73.83M | 150.78%87.92M | 14.86%41.15M | -26.35%26.66M | -26.35%26.66M | -66.13%31.17M | -15.00%35.06M | 4.13%35.83M | -0.86%36.19M | -0.86%36.19M |
| Free cash flow | 16.89%-19.09M | 380.74%58.9M | -4.22%-25.31M | 7.62%-91.47M | -17.28%-23.24M | 18.44%-22.97M | 26.86%-20.98M | -8.66%-24.29M | -23.47%-99.01M | 11.46%-19.81M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data